1. Home
  2. UE vs DYN Comparison

UE vs DYN Comparison

Compare UE & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Urban Edge Properties of Beneficial Interest

UE

Urban Edge Properties of Beneficial Interest

HOLD

Current Price

$21.07

Market Cap

2.6B

Sector

Finance

ML Signal

HOLD

DYN

Dyne Therapeutics Inc.

HOLD

Current Price

$15.48

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UE
DYN
Founded
2014
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.6B
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
UE
DYN
Price
$21.07
$15.48
Analyst Decision
Hold
Strong Buy
Analyst Count
5
16
Target Price
$22.00
$38.63
AVG Volume (30 Days)
937.3K
1.6M
Earning Date
05-13-2026
06-03-2026
Dividend Yield
4.01%
N/A
EPS Growth
23.33
N/A
EPS
0.74
N/A
Revenue
$471,935,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$28.32
N/A
Revenue Growth
6.06
N/A
52 Week Low
$15.66
$7.01
52 Week High
$21.87
$25.00

Technical Indicators

Market Signals
Indicator
UE
DYN
Relative Strength Index (RSI) 59.68 43.72
Support Level $18.53 $14.67
Resistance Level $21.68 $19.65
Average True Range (ATR) 0.40 0.95
MACD -0.03 0.03
Stochastic Oscillator 50.71 52.77

Price Performance

Historical Comparison
UE
DYN

About UE Urban Edge Properties of Beneficial Interest

Urban Edge Properties is a real estate investment trust principally focused on the management and development of retail real estate properties in urban communities in the U.S. Having originally been created to hold the majority of Vornado Realty Trust's shopping center businesses, Urban Edge's asset portfolio is mostly composed of shopping centers and malls in terms of total square footage. The company's holdings include necessity and convenience-oriented retailers, such as department stores, grocers, health clubs, and restaurants. Urban Edge's properties are mainly located in the New York City metropolitan region and within the DC to Boston corridor. The company generates nearly all of its revenue through the collection of rent from a large number of tenants.

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

Share on Social Networks: